16 – 30 of 307
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Associations of phosphorylated tau pathology with whole-hemisphere ex vivo morphometry in 7 tesla MRI
(
- Contribution to journal › Article
-
Mark
Longitudinal amyloid and tau PET imaging in Alzheimer's disease : A systematic review of methodologies and factors affecting quantification
(
- Contribution to journal › Scientific review
-
Mark
Neuroinflammation and amyloid-β in early Alzheimer’s disease. Insight into the earliest events using mouse models
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Maternal separation differentially modulates early pathology by sex in 5xFAD Alzheimer’s disease-transgenic mice
(
- Contribution to journal › Article
-
Mark
Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Sex differences in associations between APOE ε2 and longitudinal cognitive decline
(
- Contribution to journal › Article
-
Mark
CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers
(
- Contribution to journal › Article
-
Mark
Sex differences in disease progression in Alzheimer patients with different concomitant medications.
2023) 17th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2023)(
- Contribution to conference › Abstract
-
Mark
Endocannabinoid System Biomarkers in Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Robustness of CSF Aβ42/40 and Aβ42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes
(
- Contribution to journal › Article
-
Mark
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Clinical performance and robustness evaluation of plasma amyloid-β42/40 prescreening
(
- Contribution to journal › Article
-
Mark
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
(
- Contribution to journal › Article